Lv et al. [36] confirmed that low pSUVmax is integrated with mutant EGFR status and could be associated with other clinical factors to improve the discriminability of the EGFR mutation status in several NSCLC patients whose EGFR testing is unavailable. Here, EGFR is linked to non-small cell lung carcinoma.